亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Challenges in diagnostics and treatment of infant-type hemispheric gliomas

医学 肿瘤科 无症状的 化疗 靶向治疗 队列 疾病 内科学 神经影像学 病理 癌症 精神科
作者
L. I. Papusha,Margarita Zaytseva,М. А. Сенченко,Agnesa Panferova,Agunda Sanakoeva,А. В. Артемов,A. M. Korostyshevskaya,Alexandra Tarakanova,D. A. Murzaeva,Igor Kasich,А. А. Merishavyan,Andrey Flegontov,Ekaterina Salnikova,A. N. Zaychikov,Inna Proleskovskaya,Yu. V. Dinikina,Z.Kh. Kumykova,A. V. Protsvetkina,Natalia Usman,Alexander Karachunskiy
出处
期刊:Neuro-oncology advances [Oxford University Press]
卷期号:7 (1): vdaf124-vdaf124 被引量:1
标识
DOI:10.1093/noajnl/vdaf124
摘要

Abstract Background Infant-type hemispheric gliomas (IHG) represent a novel entity, first codified in the WHO CNS 5 classification. Due to their rarity, as well as their neuroimaging and histopathologic heterogeneity, definitive diagnosis can be challenging. In the majority of cases, the tumors are large, and difficult to fully resect. The efficacy of standard cytotoxic chemotherapy remains unclear. IHGs frequently contain receptor tyrosine-kinase (RTK) gene fusions, denoting a potential vulnerability to targeted therapy by small molecule RTK inhibitors. Methods We report 15 patients with IHG receiving treatment during a five-year period. Integrated diagnosis was achieved combining histopathology, DNA methylation profiling and RNA sequencing. Ten out of 15 patients received chemotherapy. Targeted therapy with entrectinib or lorlatinib was prescribed in five patients after progression and in one as first line treatment. Results The median follow-up was 1.5 years (range, 0.1-5.1 years). Six patients were asymptomatic despite large volumes and diagnosed during routine ultrasound screening. Neuroimaging revealed two general radiographic presentation, either cystic-solid or purely solid masses. These radiologic subtypes were not associated with differences in histology or clinical behavior, but demonstrated differential gene expression profiles. Standard cytotoxic chemotherapy was administered in ten patients, in six of them disease progression was observed (all with residual tumor). RTK gene fusions were revealed in all cases. Six patients were treated with targeted therapies. All patients had an initial tumor response; following which 2 had disease progression. One-year event-free survival for the entire cohort was 47% (CI 27-80%), 2-year overall survival was 61% (CI 39-95%). Conclusions IHGs are comprised of two radiologically and molecularly distinct groups. Huge cystic tumors are frequently associated with life threating complications. The limited efficacy of the standard cytotoxic chemotherapy and presence of kinase fusion in nearly all cases render patients with IHG candidates for targeted therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NN完成签到,获得积分10
11秒前
19秒前
外向如雪完成签到,获得积分10
32秒前
隐形曼青的应助被gtgyh采纳,获得10
48秒前
55秒前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
gtgyh发布了新的文献求助10
1分钟前
present发布了新的文献求助10
1分钟前
似水流年完成签到 ,获得积分10
1分钟前
酷酷海豚完成签到,获得积分10
1分钟前
1分钟前
Yang发布了新的文献求助10
1分钟前
酷波er的应助被Ava采纳,获得30
1分钟前
Yang完成签到,获得积分10
1分钟前
靓丽的淇完成签到,获得积分10
1分钟前
Tree_QD完成签到 ,获得积分10
1分钟前
酷波er的应助被羊羊吃芋圆采纳,获得10
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
微笑艳一完成签到,获得积分10
2分钟前
Ava发布了新的文献求助30
2分钟前
3分钟前
3分钟前
复杂亦瑶完成签到,获得积分10
3分钟前
爆米花的应助被amiee采纳,获得10
3分钟前
tsuki完成签到,获得积分10
3分钟前
科研通AI6.2的应助被Prof.Z采纳,获得10
3分钟前
完美世界的应助被whc采纳,获得10
3分钟前
3分钟前
amiee发布了新的文献求助10
3分钟前
jennica发布了新的文献求助30
4分钟前
yc关闭了yc的文献求助
4分钟前
4分钟前
漂亮的新梅完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190148
求助须知:如何正确求助?哪些是违规求助? 9577257
关于积分的说明 21852289
捐赠科研通 7788541
什么是DOI,文献DOI怎么找? 3436279
关于科研通互助平台的介绍 2560044
邀请新用户注册赠送积分活动 2482880